| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-8300 [G. Y., Q. D., X-O. S., M. S., W. Z.]; University of South Carolina School of Medicine, Columbia, South Carolina 29203 [G. L., R. B., X-Y. P.]; Shanghai Cancer Institute, Shanghai, People’s Republic of China 200032 [F. J., J-R. C.]
Insulin resistance has been suggested to be associated with an increased risk of breast cancer. Insulin sensitivity can be measured using blood C-peptide, a marker of insulin secretion. It is thus conceivable that blood C-peptide levels may be associated with breast cancer risk. To evaluate this hypothesis, we analyzed data from a subset (143 case-control pairs matched by age and status of menopause) of women who participated in the Shanghai Breast Cancer Study, a population-based, case-control study conducted in Shanghai during 1996–1998. Fasting blood samples were collected from study subjects to measure C-peptide levels. For cancer patients, the samples were collected before any cancer therapy. Conditional logistic regression was used to estimate adjusted odds ratios and 95% confidence intervals related to C-peptide levels. Breast cancer risk was increased with increasing levels of C-peptide (trend test, P = 0.01), with an odds ratio of 2.7 (95% confidence interval = 1.2–5.9) observed for the highest compared with the lowest tertile of C-peptide concentration after adjusting for body mass index and age at the first live birth. The risk was not altered after fully adjusting for other traditional risk factors for breast cancer. This positive association was observed in both pre and postmenopausal women and regardless of the levels of waist-to-hip ratio or body mass index. The results from this study were consistent with the insulin-resistance hypothesis for breast cancer and suggest that increased levels of C-peptide may contribute to the development of breast cancer.
This article has been cited by other articles:
|
|
 |
|
  D. P. Rose, S. M. Haffner, and J. Baillargeon Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women Endocr. Rev., December 1, 2007; 28(7): 763 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lin, P. M. Ridker, N. Rifai, I-M. Lee, J. E. Manson, J. E. Buring, and S. M. Zhang A Prospective Study of Hemoglobin A1c Concentrations and Risk of Breast Cancer in Women. Cancer Res., March 1, 2006; 66(5): 2869 - 2875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Chang, R. G. Ziegler, B. Dunn, R. Stolzenberg-Solomon, J. V. Lacey Jr., W.-Y. Huang, A. Schatzkin, D. Reding, R. N. Hoover, P. Hartge, et al. Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 334 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zheng, W.-H. Chow, G. Yang, F. Jin, N. Rothman, A. Blair, H.-L. Li, W. Wen, B.-T. Ji, Q. Li, et al. The Shanghai Women's Health Study: Rationale, Study Design, and Baseline Characteristics Am. J. Epidemiol., December 1, 2005; 162(11): 1123 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Diorio, M. Pollak, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, S. Berube, and J. Brisson Levels of C-Peptide and Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2661 - 2664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Malin, C. E. Matthews, X.-O. Shu, H. Cai, Q. Dai, F. Jin, Y.-T. Gao, and W. Zheng Energy Balance and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1496 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Chlebowski, M. Pettinger, M. L. Stefanick, B. V. Howard, Y. Mossavar-Rahmani, and A. McTiernan Insulin, Physical Activity, and Caloric Intake in Postmenopausal Women: Breast Cancer Implications J. Clin. Oncol., November 15, 2004; 22(22): 4507 - 4513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cho, D. Spiegelman, D. J. Hunter, W. Y. Chen, G. A. Colditz, and W. C. Willett Premenopausal Dietary Carbohydrate, Glycemic Index, Glycemic Load, and Fiber in Relation to Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1153 - 1158. [Abstract] [Full Text]
|
|
|
|
|
|
C. R. Jonas, M. L. McCullough, L. R. Teras, K. A. Walker-Thurmond, M. J. Thun, and E. E. Calle Dietary Glycemic Index, Glycemic Load, and Risk of Incident Breast Cancer in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 573 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Michels, C. G. Solomon, F. B. Hu, B. A. Rosner, S. E. Hankinson, G. A. Colditz, and J. E. Manson Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses' Health Study Diabetes Care, June 1, 2003; 26(6): 1752 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Dai, X.-o. Shu, F. Jin, Y.-T. Gao, Z.-X. Ruan, and W. Zheng Consumption of Animal Foods, Cooking Methods, and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 801 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Mink, E. Shahar, W. D. Rosamond, A. J. Alberg, and A. R. Folsom Serum Insulin and Glucose Levels and Breast Cancer Incidence: The Atherosclerosis Risk in Communities Study Am. J. Epidemiol., August 15, 2002; 156(4): 349 - 352. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
